Earnouts are a staple of life sciences M&A. They bridge valuation gaps, allocate regulatory risk, and align incentives around post-closing development. But they also generate some of the most...
Last month, the Delaware Court of Chancery issued an important decision via memorandum opinion on a variety of issues...
Boston Scientific Corp. did not have reasonable grounds to terminate its planned $275 million merger with an early stage...
The Delaware Chancery Court rebuffed a shareholder demand for records related to a $38 billion merger between two Texas...
The Delaware Chancery Court recently held that emails between Radixx Solutions and its attorneys were off limits to RSI...
The Delaware Court of Chancery’s recent ruling that Rent-A-Center was within its right to walk away from a $1...
The Federal Trade Commission recently announced annual changes to the reporting thresholds for the Hart Scott Rodino Antitrust Improvements...
The Delaware Supreme Court has upheld a lower court’s decision to dismiss smart home company Alarm.com’s trade secrets case...
The Delaware Supreme Court has upheld a landmark lower court decision that allowed Fresenius Kabi AG to walk away...
The Delaware Supreme Court recently upheld a lower court’s decision to dismiss a shareholder lawsuit challenging a $125 buyout...
Categories
